Cutler Group LP Provention Bio, Inc. Put Options Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 Apr 14, 2022	SELL	$3.4 - $7.88 $680 - $1,576	-200 Reduced 11.11%	1,600 $0
Q4 2021 Jan 18, 2022	BUY	$5.59 - $7.39 $1,677 - $2,217	300 Added 20.0%	1,800 $5,000
Q3 2021 Oct 26, 2021	SELL	$5.66 - $8.33 $6,226 - $9,163	-1,100 Reduced 42.31%	1,500 $3,000
Q2 2021 Jul 19, 2021	BUY	$6.71 - $11.04 $10,736 - $17,664	1,600 Added 160.0%	2,600 $5,000
Q3 2020 Oct 27, 2020	BUY	$10.34 - $15.2 $3,102 - $4,560	300 Added 42.86%	1,000 $4,000
Q2 2020 Jul 22, 2020	SELL	$7.81 - $17.0 $2,343 - $5,100	-300 Reduced 30.0%	700 $0
Q1 2020 May 07, 2020	SELL	$5.42 - $17.75 $5,420 - $17,750	-1,000 Reduced 50.0%	1,000 $0
Q4 2019 Feb 06, 2020	SELL	$5.84 - $14.9 $12,264 - $31,290	-2,100 Reduced 51.22%	2,000 $0
Q3 2019 Oct 28, 2019	BUY	$6.83 - $13.0 $21,173 - $40,300	3,100 Added 310.0%	4,100 $16,000
Q2 2019 Aug 09, 2019	BUY	$2.3 - $13.79 $2,300 - $13,790	1,000 New	1,000 $4,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.